Lilly Swings to Loss on ImClone Costs
Lilly reaffirmed previously offered 2009 earnings guidance in the range of $4 to $4.25 a share, which includes a dilution from the ImClone acquisition in the range of 30 cent to 35 cents a share. Excluding the ImClone-related charges, Lilly said it will earn $4.35 to $4.55 a share in 2009.
- More on LLY
- Cramer's Diversified Dividend Portfolio
- Traders Brace for Drop in Eli Lilly Shares
- Lilly Expects Earnings Growth in 2010
- Practicing Balance With P&G: China Watch
- Eli Lilly: Analysts' Upgrades, Downgrades
- Evan Bayh: Hypocrisy on the Public Option
- Lilly Beats on Top, Bottom Lines
- Amylin Holder Sells $54M Worth
- Eli Lilly: Analysts' Upgrades, Downgrades
- Stock Search: China, President Rev Up Stocks
- Market Activity
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,452.00 | 1,107.93 | 2,201.05 | 36.03 |
Oil *
72.19
|
|
DOWN
49.05
|
DOWN
6.18
|
DOWN
11.05
|
UP
0.57
|
10 Yr
3.60%
SPDR Gold
110.21
|
|
-0.47%
|
-0.55%
|
-0.50%
|
+1.61%
|
Data delayed 20 minutes |
